Alexander M. Belov
Alexander M. Belov has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Irina A. Baranova
Pirogov Russian National Research Medical University (Pirogov University)
2 shared publications - Tatiana A. Bakhareva
Federal State Autonomous Educational Institution of Higher Education “N.I.Pirogov Russian National Research Medical University” of the Ministry of Health of the Russian Federation
2 shared publications - Arthur I. Yusupov
Research Institute of Pulmonology
1 shared publication - Stanislav D. Gorbunkov
Federal State Budgetary Institution “Pulmonology Scientific Research Institute” under Federal Medical and Biological Agency of Russian Federation
1 shared publication А. М. Белов
Федеральное государственное бюджетное учреждение «Объединенная больница с поликлиникой» Управления делами Президента Российской Федерации
1 shared publication- Бахарева Татьяна Александровна
ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России (Пироговский Университет)
1 shared publication
Latest Publications
- Open Access
- 12 August 2026
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 36 (4) , 678-684
Polysomnographic characteristics of obstructive sleep apnea in obese patients
The available scientific research does not sufficiently describe the specific polysomnographic (PSG) characteristics of obstructive sleep apnea (OSA) in obese patients. The aim was to determine the clinical and PSG characteristics of OSA in obese patients. Methods . The study included retrospective analysis of medical histories, assessment of the frequency of concomitant and previous diseases, and analysis of PSG results (Сomet PSG, Grass Technologies, USA). Results . The study included 2 groups of patients: the main group with OSA and BMI > 30 kg/m2 (n = 100) and the control group with OSA and BMI 18 – 25 kg/m2 (n = 44). In the main group, the Charlson comorbidity index (p = 0.012), the likelihood of hypertension (OR 6.4 (95% CI 2.9 – 14.2)), type 2 diabetes mellitus or impaired glucose tolerance (OR 29.9 (95% CI 3.9 – 225.7)), dyslipidemia (OR 2.4 (95% CI 1.1 – 4.9)), and ahistory of pneumonia (OR 3.2 (95% CI 1.1 – 8.9)) were higher than in control group. The PSG analysis revealed that severe OSA was detected in mostpatients (52%) of the main group and in none of the patients in the control group. Duration of SpO 2 < 90% was longer in the main group (42.4 min), than in the control group (0.9 min). The apnea-hypopnea index was increased in the REM sleep stage and in supine position in the main group. Duration of sleep stages was different: stage 1 was longer in the main group and stage 2 was longer in the control group. There were no differences in REM and stage 3. Obese patients had more frequent arousals, due to episodes of apnea and hypopnea and snoring. Conclusion . Our study identified certain characteristics of PSG in OSA and obesity, which may explain the higher incidence of concomitant severe diseases that may be associated with cardio-renal-metabolic syndrome.
- 12 August 2026
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 36 (4) , 678-684
Open AccessPolysomnographic characteristics of obstructive sleep apnea in obese patients
The available scientific research does not sufficiently describe the specific polysomnographic (PSG) characteristics of obstructive sleep apnea (OSA) in obese patients. The aim was to determine the clinical and PSG characteristics of OSA in obese patients. Methods . The study included retrospective analysis of medical histories, assessment of the frequency of concomitant and previous diseases, and analysis of PSG results (Сomet PSG, Grass Technologies, USA). Results . The study included 2 groups of patients: the main group with OSA and BMI > 30 kg/m2 (n = 100) and the control group with OSA and BMI 18 – 25 kg/m2 (n = 44). In the main group, the Charlson comorbidity index (p = 0.012), the likelihood of hypertension (OR 6.4 (95% CI 2.9 – 14.2)), type 2 diabetes mellitus or impaired glucose tolerance (OR 29.9 (95% CI 3.9 – 225.7)), dyslipidemia (OR 2.4 (95% CI 1.1 – 4.9)), and ahistory of pneumonia (OR 3.2 (95% CI 1.1 – 8.9)) were higher than in control group. The PSG analysis revealed that severe OSA was detected in mostpatients (52%) of the main group and in none of the patients in the control group. Duration of SpO 2 < 90% was longer in the main group (42.4 min), than in the control group (0.9 min). The apnea-hypopnea index was increased in the REM sleep stage and in supine position in the main group. Duration of sleep stages was different: stage 1 was longer in the main group and stage 2 was longer in the control group. There were no differences in REM and stage 3. Obese patients had more frequent arousals, due to episodes of apnea and hypopnea and snoring. Conclusion . Our study identified certain characteristics of PSG in OSA and obesity, which may explain the higher incidence of concomitant severe diseases that may be associated with cardio-renal-metabolic syndrome.
- Open Access
- 17 March 2026
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 98 (3) , 183-188
Pulmometabolic syndrome: a review
In this review, we discuss the underexplored issue of the relationship between metabolic syndrome (MS) and respiratory diseases. The review discusses the main pathogenic mechanisms, including chronic low-grade inflammation, oxidative stress, endothelial dysfunction, and mechanical restriction of lung volumes. The concept of pulmonometabolic syndrome is introduced. Data of the results of studies of the functional parameters of the lungs in MS are presented. We describe the clinical and pathobiological characteristics of the mutually aggravating interaction between MS and respiratory disorders, such as chronic obstructive pulmonary disease, bronchial asthma, obstructive sleep apnea, lung cancer, and pulmonary hypertension.
- 17 March 2026
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 98 (3) , 183-188
Open AccessPulmometabolic syndrome: a review
In this review, we discuss the underexplored issue of the relationship between metabolic syndrome (MS) and respiratory diseases. The review discusses the main pathogenic mechanisms, including chronic low-grade inflammation, oxidative stress, endothelial dysfunction, and mechanical restriction of lung volumes. The concept of pulmonometabolic syndrome is introduced. Data of the results of studies of the functional parameters of the lungs in MS are presented. We describe the clinical and pathobiological characteristics of the mutually aggravating interaction between MS and respiratory disorders, such as chronic obstructive pulmonary disease, bronchial asthma, obstructive sleep apnea, lung cancer, and pulmonary hypertension.